On February 17th, 2022 the Sino-EU PerMed project organised a stakeholder workshop with the aim to present the Personalised Medicine landscape in Europe and China, highlight the main challenges to scientific and technological collaboration and initiate a debate on how to strengthen research and innovation between the two Regions. As a result, the Sino-EU PerMed Consortium, together with the Science & Technology Expert Task Force, have elaborated a set of recommendations for policymakers which are now presented in the Sino-EU PerMed Policy Brief.
The document addresses three topics:
- PM landscape in EU and China,
- Traditional Chinese Medicine in PM and
- Data sharing.
For each topic the barriers and needs are identified and corresponding recommendations are provided.
The Policy Paper will also be presented in the upcoming S&T Webinar on Perspectives in Personalised Medicine: genomics, rare diseases, devices on September 13th.
Sino-EU PerMed is part of the 'ICPerMed family'.